selected publications
- Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellows. Seminars in arthritis and rheumatism. 2024 Academic Article GET IT
- Erratum to "2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective" [The Journal of Arthroplasty 38 (2023) 2193-2201]. 2023 GET IT
- Anticitrullinated peptide antibody epitope expansion and the HLA DRB1 'shared epitope' are less common in seropositive checkpoint inhibitor-induced inflammatory arthritis than in longstanding rheumatoid arthritis. RMD open. 2023 Academic Article GET IT
-
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis.
Annals of the rheumatic diseases.
2023
Academic Article
GET IT
Times cited: 19 - Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: international development of a glucocorticoid treatment-specific patient-reported outcome measure. Rheumatology (Oxford, England). 2023 Academic Article GET IT
- Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group. Seminars in arthritis and rheumatism. 2022 Review GET IT
- Rheumatic Complications of Immune Checkpoint Inhibitors. Rheumatic diseases clinics of North America. 2022 Review GET IT
-
Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition.
Journal for immunotherapy of cancer.
2022
Academic Article
GET IT
Times cited: 30 - Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set. Seminars in arthritis and rheumatism. 2021 Academic Article GET IT
- Rheumatic Complications of Immune Checkpoint Inhibitors. The Medical clinics of North America. 2021 Information Resource GET IT
- Higher Checkpoint Inhibitor Arthritis Disease Activity may be Associated With Cancer Progression: Results From an Observational Registry. ACR open rheumatology. 2020 Academic Article GET IT
- Recurrent Complement-Mediated Thrombotic Microangiopathy in a Patient with Systemic Lupus Erythematosus: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2020 Academic Article GET IT
- Checkpoint Inhibitor-Associated Autoimmunity: What a Rheumatologist Needs to Know. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2019 Academic Article GET IT
-
Social Determinants of Health Training in U.S. Primary Care Residency Programs: A Scoping Review.
Academic medicine : journal of the Association of American Medical Colleges.
2019
Information Resource
GET IT
Times cited: 15 -
Nonradiographic axial spondyloarthritis: clinical and therapeutic relevance.
Arthritis research & therapy.
2017
Information Resource
GET IT
Times cited: 20 -
Moving beyond the limitations of the visual analog scale for measuring pain: novel use of the general labeled magnitude scale in a clinical setting.
American journal of physical medicine & rehabilitation.
2014
Academic Article
GET IT
Times cited: 16 - A Review of Spasticity Treatments: Pharmacological and Interventional Approaches. Critical reviews in physical and rehabilitation medicine. 2013 Academic Article GET IT